A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lazertinib | CAS 1903008-80-9 - Request Quote

Picture of Lazertinib
SZ CAT No:SZ-L127001
CAS No
1903008-80-9
Mol.F.
C30H34N8O3
Mol.Wt.
554.7
Inv. Status
Synthesis on demand
Rel. CAS No2247995-38-4 (HCl salt) ; 2247995-37-3 (Mesylate salt) ; 2247995-39-5(Citrate salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lazertinib is chemically N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide. Lazertinib is supplied with detailed characterization data compliant with regulatory guideline. Lazertinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lazertinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1903008-80-9

Purchase 1903008-80-9

Order 1903008-80-9

Enquire 1903008-80-9

price of 1903008-80-9

1903008-80-9 Supplier

1903008-80-9 Manufacturer

1903008-80-9 Exporter

buy high quality Lazertinib

Purchase Lazertinib

Lazertinib suppliers

Lazertinib manufacturers

Lazertinib price

Order Lazertinib

Enquire Lazertinib

Lazertinib cost

Lazertinib Supplier

Lazertinib Distributor

Lazertinib for Method Validation

Lazertinib Reference Standard

Lazertinib for ANDA Filing

Lazertinib for Forced Degradation Studies

Lazertinib Identification Standards

Lazertinib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,